Date: Dec 1, 2020 01:00 AM - Dec 20, 2020 11:55 PM
CE Hours
CE Units
Registration closes on Dec 20, 2020 01:00 AM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
REGISTRATION NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.
If paying by check please mail to the address below: 301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
|
|
![]() |
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor approximately 2 to 3 weeks after the program and you have completed any needed requirements. **No partial credit will be available**
|
Co-Sponsor(s)
Support/Credits
- UNC Health System Employees and UNC ESOP Students should register using your UNC email address. UNC Employees - please select your employment location during the registration process. UNC Students - please respond "Yes" to the "Are you a UNC Student" question.
- Select the “Check” payment method on the registration page. Your employment will be verified prior to credit being uploaded
Registration closes on Dec 20, 2020
at 01:00 AM
Registration Closed
Meeting: 160 483 1545
Password: UNCPharm1
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content
Objectives
- Describe the pathophysiology, clinical manifestations, and diagnosis of acute ischemic stroke (AIS)
- Outline the literature examining outcomes for administering alteplase in AIS
- Discuss evidence-based recommendations regarding the appropriate use of alteplase in AIS
- Apply appropriate use of alteplase in AIS to a patient case
Speaker(s)/Author(s)
Sarah Elizabeth Davis, PharmD
|
Activity Number
0046-9999-20-376-L01-PCE Hours
Location
Registration closes on Dec 20, 2020
at 01:00 AM
Registration Closed
Meeting ID: 160 925 2086
Password: UNCPharm1
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content
Objectives
- Outline the pathophysiology, assessment, and consequence of platelet dysfunction with LVADs
- Discuss the historical use of anti-platelet agents in patients with left ventricular assist devices (LVADs)
- Analyze the evidence behind current anti-thrombotic practices in patients with an LVAD
- Discuss the risks and benefits of anti-platelet therapy in addition to anticoagulation in patients with an LVAD
Speaker(s)/Author(s)
Ryan Vesper, PharmD
|
Activity Number
0046-9999-20-341-L01-PCE Hours
Location
Registration closes on Dec 20, 2020
at 01:00 AM
Registration Closed
Meeting: 160 295 0905
Password: UNCPharm1
Presentation Slides available for download at the bottom of this module. You MUST be signed into your registered account to access this content
Objectives
- Discuss Mycobacterium abscessus-associated pulmonary disease in pediatric cystic fibrosis patients
- Identify guideline based therapy recommended to treat Mycobacterium abscessus pulmonary disease
- Discuss the pharmacology and clinical concerns associated with the use of clofazimine
- Outline a plan for treatment of refractory Mycobacterium abscessus pulmonary disease including clofazimine
Speaker(s)/Author(s)
Matt Whiteman, PharmD
|